PERRELLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.124
EU - Europa 554
AS - Asia 226
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 1.908
Nazione #
US - Stati Uniti d'America 1.120
IT - Italia 214
CN - Cina 123
IE - Irlanda 109
SE - Svezia 76
UA - Ucraina 39
SG - Singapore 31
VN - Vietnam 27
GB - Regno Unito 23
DE - Germania 19
FR - Francia 17
HK - Hong Kong 14
PL - Polonia 14
KR - Corea 10
BE - Belgio 9
ES - Italia 8
IN - India 8
JP - Giappone 7
NL - Olanda 7
FI - Finlandia 5
TW - Taiwan 5
CA - Canada 4
DK - Danimarca 3
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HR - Croazia 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 1.908
Città #
Chandler 221
Ashburn 109
Dublin 109
Fairfield 100
Torino 96
Woodbridge 57
Beijing 51
Seattle 45
Nyköping 42
Houston 41
Jacksonville 39
Wilmington 34
Cambridge 31
Ann Arbor 25
Pisa 24
Singapore 24
Medford 20
Turin 17
Princeton 15
Warsaw 12
Boston 11
Dong Ket 11
Fremont 11
San Mateo 11
Xian 11
Milan 10
Dearborn 9
Nanjing 9
Brussels 7
Central District 7
Hangzhou 7
New York 7
Seoul 7
Shanghai 7
Hong Kong 6
Redwood City 6
Norwalk 5
Vigo 5
Villeurbanne 5
Aosta 4
Edinburgh 4
Helsinki 4
Pune 4
San Diego 4
Taipei 4
Copenhagen 3
Fontana 3
Gouda 3
Guangzhou 3
Gunzenhausen 3
Hefei 3
Kunming 3
Los Angeles 3
Rochester 3
Santiago De Compostela 3
Toronto 3
Baotou 2
Berlin 2
Boardman 2
Bromsgrove 2
Chieri 2
Cuneo 2
Feltre 2
Frankfurt am Main 2
Genova 2
Greifswald 2
Hebei 2
Jinan 2
London 2
Mountain View 2
Phoenix 2
Rome 2
Silver Spring 2
Tokyo 2
White Lake 2
Abidjan 1
Akron 1
Albuquerque 1
Amersfoort 1
Auckland 1
Bethesda 1
Birmingham 1
Bognor Regis 1
Brno 1
Cardiff 1
Changsha 1
Chengdu 1
Chicago 1
Falls Church 1
Gwangju 1
Göttingen 1
Hamburg 1
Ithaca 1
Kwangju 1
Maastricht 1
Meta 1
Moncalieri 1
Mumbai 1
Nanchang 1
Napoli 1
Totale 1.384
Nome #
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 195
Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function 140
Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases 128
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 124
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 108
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation 103
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins 100
KRIT1 loss of function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 80
Vitamin D deficiency and the risk of cerebrovascular disease 79
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease 73
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 73
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 70
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM) 69
Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications 64
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 63
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 62
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease 61
KRIT1 loss-of-function induces a sustained Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 61
Dicarbonyl stress and S-glutathionylation in cerebrovascular diseases: A focus on cerebral cavernous malformations 58
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease 53
Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1 50
Fluorescence Analysis of Reactive Oxygen Species (ROS) in Cellular Models of Cerebral Cavernous Malformation Disease 45
Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease 42
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease 24
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 18
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease 15
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM) 13
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events 7
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease 5
Totale 1.983
Categoria #
all - tutte 7.872
article - articoli 0
book - libri 0
conference - conferenze 2.309
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 14 8 5 32 13 15 39 39 49 26 25 19
2020/2021385 20 33 68 9 27 21 16 40 45 38 27 41
2021/2022362 30 2 17 13 33 8 25 26 5 23 95 85
2022/2023518 53 57 20 76 24 118 32 31 60 8 31 8
2023/2024269 41 58 4 12 10 24 6 50 2 15 15 32
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.983